Hospital groups nationwide are adopting programs and policies aimed at making childbirth safer. The move comes in the wake of soaring liability insurance premiums for obstetric units, as well as mounting evidence that labor-inducing drugs and other delivery room practices are endangering mothers and infants, according to the Wall Street Journal (7/12/2006).
Hospital groups nationwide are adopting programs and policies aimed at making childbirth safer. The move comes in the wake of soaring liability insurance premiums for obstetric units, as well as mounting evidence that labor-inducing drugs and other delivery room practices are endangering mothers and infants, according to the Wall Street Journal (7/12/2006).
Several risk-management initiatives are being adopted in obstetric units. To reduce the risk of emergency cesarean deliveries, admissions to neonatal intensive care units, and long-term health issues for children, some hospital groups are making it harder to schedule inducements before the 39-week minimum, unless medically necessary. They are also curtailing the use of drugs such as oxytocin, which at too-high doses can lead to ruptures of the uterus and fetal distress or death; and limiting the use of forceps and vacuums.
Additionally, physicians and nurses are being encouraged to use the same terms when reading heart monitors-using differing terminology often leads to miscommunication as to when an infant may be in distress. Finally, some hospitals have taken steps to educate mothers-to-be about the risks of early induction.
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More